Skip to content
Search

Latest Stories

New report reveals significant awarding and attainment gaps for Black trainees in pharmacy education

New report reveals significant awarding and attainment gaps for Black trainees in pharmacy education

This persisting issue leads to the profession losing talented potential pharmacists from underrepresented and diverse backgrounds, says BPSA President 

The Royal Pharmaceutical Society (RPS) has called for action on differential degree awarding and registration assessment attainment gaps for Black trainees in initial pharmacy education and training.


According to a new report published by the RPS on Tuesday (6 February), there’s a pharmacy degree awarding gap of 12 per cent and a registration assessment attainment gap of 22.6 per cent between Black and White trainees.

The variation in pharmacy attainment for Black trainees was first recorded by the General Pharmaceutical Council (GPhC) in 2013, and the Pharmaceutical Journal has been tracking the awarding gap at undergraduate level.

Even after a decade, significant differences exist in the awarding and attainment gaps for Black students and trainees compared to their White counterparts, the report said.

Amandeep Doll, RPS Head of Professional Belonging and Engagement and lead author of the report, commented: “The gaps that persist are inequitable and deeply disappointing, with real world impacts on individuals and their careers.”

“This report is a call to action for the entire pharmacy community to prioritise the reduction of degree awarding and registration differential attainment gaps and provide greater equity for Black trainees.”

She reiterated that RPS and its partner organisations are committed to addressing this issue.

“By working together, and implementing the recommendations of the report, we can make a real difference and create a more inclusive and diverse pharmacy profession which ultimately benefits patient care,” she added.

To create the report, the RPS collaborated with several other stakeholders including the British Pharmaceutical Students' Association (BPSA), the Black Pharmacists Collective, the Black Pharmacist Initiative, the General Pharmaceutical Council (GPhC), NHS England Chief Pharmaceutical Officer’s Team and the Pharmacy Schools Council.

BPSA President Nonyelum Anigbo expressed concern that the differential attainment gap continues to hold back many Black trainee pharmacists from becoming qualified, leading to the profession losing “talented potential pharmacists” from underrepresented and diverse backgrounds.

“Equitable changes need to be made to ensure Black pharmacy students and trainees are given opportunities and support to reach their full potential and successfully join the pharmacy workforce,” she said.

To tackle the gap, the report recommended that data collection and analysis should be improved and role models should be promoted.

Additionally, it suggested removing bias from processes and providing support during the transition from pharmacy student to foundation training placements.

Furthermore, the report emphasised the importance of educational supervisor training, the implementation of protected learning time in foundation trainee placements, and an annual equality, diversity and inclusion forum to ensure good practice is being shared across Schools of Pharmacy and training placements.

As informed by the RPS, smaller task and finish groups will be created to act on the recommendations, and there will be a working group meeting every six months to update on actions.

Addressing the differential attainment gap is also one of the top priorities for NHS England’s Inclusive Pharmacy Practice Programme, which is supported by RPS, APTUK and 13 other national partner organisations.

More For You

13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less
 Government launches call for evidence on England’s first ever men’s health strategy

Wes Streeting

Pic credit: Getty images

Call for Evidence: Streeting urges public to help shape men’s health strategy

The government is urging men of all ages to come forward and contribute to the development of England’s first-ever men’s health strategy, a key initiative under its Plan for Change.

On Thursday (24), the Department of Health and Social Care (DHSC) launched a 12-week call for evidence, seeking insights from the public, health and social care professionals, academics and employers on ways to prevent and tackle the biggest issues facing men.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less